|
| Status |
Public on Sep 03, 2020 |
| Title |
FiTAc-seq analysis of PDX 14-07 and MMTV-rtTA/tetO/Her2 tumors treated with abemaciclib |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
We measured changes in H3K27ac after treatment of PDX 14-07 or MMTV-rtTA/tetO-Her2 tumors implanted in nude mice with abemaciclib
|
| |
|
| Overall design |
Examination of changes in H3K27ac in PDX 14-07 and MMTV-rtTA/tetO-Her2 tumors after treatment with abemaciclib (90 mg/kg) for 21-28 days (PDX) or 40 days (MMTV-Her2)
|
| Web link |
https://www.nature.com/articles/s43018-020-00135-y
|
| |
|
| Contributor(s) |
Goel S |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Sep 02, 2020 |
| Last update date |
Nov 10, 2020 |
| Contact name |
Shom Goel |
| E-mail(s) |
Shom.Goel@petermac.org
|
| Organization name |
Peter MacCallum Cancer Centre
|
| Lab |
Goel Lab
|
| Street address |
305 Grattan Street
|
| City |
Melbourne |
| State/province |
VIC |
| ZIP/Postal code |
3000 |
| Country |
Australia |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (8)
|
|
| Relations |
| BioProject |
PRJNA661090 |
| SRA |
SRP279856 |
Less...
More...